1. Home
  2. PODD vs TPL Comparison

PODD vs TPL Comparison

Compare PODD & TPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • TPL
  • Stock Information
  • Founded
  • PODD 2000
  • TPL 1888
  • Country
  • PODD United States
  • TPL United States
  • Employees
  • PODD N/A
  • TPL N/A
  • Industry
  • PODD Medical/Dental Instruments
  • TPL Oil & Gas Production
  • Sector
  • PODD Health Care
  • TPL Energy
  • Exchange
  • PODD Nasdaq
  • TPL Nasdaq
  • Market Cap
  • PODD 22.1B
  • TPL 21.7B
  • IPO Year
  • PODD 2007
  • TPL N/A
  • Fundamental
  • Price
  • PODD $344.71
  • TPL $908.11
  • Analyst Decision
  • PODD Strong Buy
  • TPL
  • Analyst Count
  • PODD 19
  • TPL 0
  • Target Price
  • PODD $356.58
  • TPL N/A
  • AVG Volume (30 Days)
  • PODD 575.3K
  • TPL 118.6K
  • Earning Date
  • PODD 11-06-2025
  • TPL 11-05-2025
  • Dividend Yield
  • PODD N/A
  • TPL 0.71%
  • EPS Growth
  • PODD N/A
  • TPL 6.20
  • EPS
  • PODD 3.45
  • TPL 20.70
  • Revenue
  • PODD $2,521,800,000.00
  • TPL $772,395,000.00
  • Revenue This Year
  • PODD $29.32
  • TPL $18.06
  • Revenue Next Year
  • PODD $18.37
  • TPL $11.27
  • P/E Ratio
  • PODD $100.37
  • TPL $43.76
  • Revenue Growth
  • PODD 27.11
  • TPL 12.48
  • 52 Week Low
  • PODD $230.05
  • TPL $845.56
  • 52 Week High
  • PODD $353.50
  • TPL $1,769.14
  • Technical
  • Relative Strength Index (RSI)
  • PODD 65.46
  • TPL 42.77
  • Support Level
  • PODD $324.97
  • TPL $892.00
  • Resistance Level
  • PODD $341.03
  • TPL $1,032.50
  • Average True Range (ATR)
  • PODD 12.16
  • TPL 46.18
  • MACD
  • PODD 2.13
  • TPL -5.61
  • Stochastic Oscillator
  • PODD 98.88
  • TPL 9.45

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About TPL Texas Pacific Land Corporation

Texas Pacific Land Corp is mainly engaged in the sales and leases of land owned, retaining oil and gas royalties, and the overall management of the land owned. It operates its business in two reportable segments; Land and Resource Management and Water Service and Operations. The Land and Resource Management segment focuses on managing surface acres of land and its oil and gas royalty interests, principally concentrated in the Permian Basin. The Water Services and Operations segment encompasses the business of providing full-service water offerings to operators, produced-water treatment, infrastructure development, and disposal solutions. The company generates the majority of its revenue from the Land and Resource Management segment.

Share on Social Networks: